Allegro Ophthalmics
PrivateLast Round
VC Round
Jul 24, 2017
Total Funding Raised
$22.65M
Momentum Score
25 /100
Company Overview
Allegro Ophthalmics is a biopharmaceutical company that develops novel therapies for ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allegro Ophthalmics Comps
Public and private peers based on sector, stage, and business model.
Allegro Ophthalmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2017 | ||||
| Grant | Feb 3, 2015 | ||||
| Series B | Jan 13, 2015 |
Key People
Founding team and executive leadership
Allegro Ophthalmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helmsley Charitable Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 340% MoM, reaching 1.3K.
- May 2, 2025
Monthly visitors increased 598% MoM.
Allegro Ophthalmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allegro Ophthalmics's valuation, stock price, and market status.
